 Objectives: The primary aim of this study is to define the effect of teriflunomide Aubagio on cognitive abilities in patients with relapsing multiple sclerosis MS. There are two secondary objectives, to a relate changes in cognition to vocational problems, and b determine MRI correlates of change in cognition, more specifically gray-matter GM volume metrics which the investigators believe reflect neurodegeneration. 